BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8516346)

  • 1. Reduced renal accumulation and toxicity of cisplatin in experimental galactosemia.
    Cacini W; Harden EA; Skau KA
    Proc Soc Exp Biol Med; 1993 Jul; 203(3):348-53. PubMed ID: 8516346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of cisplatin nephrotoxicity by streptozotocin-induced diabetes.
    Scott LA; Madan E; Valentovic MA
    Fundam Appl Toxicol; 1989 Apr; 12(3):530-9. PubMed ID: 2731667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of route of administration and dose on diabetes-induced protection against cisplatin nephrotoxicity.
    Sarangarajan R; Cacini W
    Proc Soc Exp Biol Med; 1996 Sep; 212(4):362-8. PubMed ID: 8751995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of streptozotocin (STZ)-induced diabetes, dextrose diuresis and acetone on cisplatin nephrotoxicity in Fischer 344 (F344) rats.
    Scott LA; Madan E; Valentovic MA
    Toxicology; 1990; 60(1-2):109-25. PubMed ID: 2107603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalization of hyperglycaemia by oral vanadyl sulfate does not reverse diabetes-induced protection against cisplatin nephrotoxicity in streptozotocin-diabetic rats.
    Sarangarajan R; Cacini W
    Pharmacol Toxicol; 1999 Oct; 85(4):169-73. PubMed ID: 10563515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal metallothionein and platinum levels in diabetic and nondiabetic rats injected with cisplatin.
    Cacini W; Singh Y
    Proc Soc Exp Biol Med; 1991 Jul; 197(3):285-9. PubMed ID: 2068122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal accumulation and urinary excretion of cisplatin in diabetic rats.
    Valentovic MA; Scott LA; Madan E; Yokel RA
    Toxicology; 1991; 70(2):151-62. PubMed ID: 1763412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early onset of cisplatin-induced nephrotoxicity in streptozotocin-diabetic rats treated with insulin.
    Sarangarajan R; Cacini W
    Basic Clin Pharmacol Toxicol; 2004 Aug; 95(2):66-71. PubMed ID: 15379782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of acetone and osmotic-diuresis by streptozotocin-induced diabetes in attenuation of cephaloridine nephrotoxicity.
    Valentovic M; Ball JG; Anestis D
    Toxicology; 1992; 71(3):245-55. PubMed ID: 1736416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-(3,5-dichlorophenyl)succinimide nephrotoxicity in streptozotocin-induced diabetic rats.
    Valentovic MA; Teets VJ; Nicoll D; Stern J; Leppla D; Rankin GO
    Toxicology; 1990 Sep; 63(3):327-39. PubMed ID: 2145659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin pharmacokinetics and its nephrotoxicity in diabetic rabbits.
    Najjar TA; Saad SY
    Chemotherapy; 2001; 47(2):128-35. PubMed ID: 11173815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between increased atrial natriuretic peptide and reduced cisplatin nephrotoxicity in rats.
    Ormond PM; Basinger MA; Jones MM; Hande KR
    J Pharmacol Exp Ther; 1992 Jul; 262(1):246-51. PubMed ID: 1385629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats.
    Osman NM; Copley MP; Litterst CL
    Cancer Chemother Pharmacol; 1984; 13(1):58-62. PubMed ID: 6428763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cephaloridine nephrotoxicity in streptozotocin induced diabetic Fischer 344 (F344) rats.
    Valentovic MA; Ball JG; Elliott C; Madan E
    Toxicology; 1989 Jul; 57(2):193-207. PubMed ID: 2749746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes-induced protection from cisplatin nephrotoxicity is associated with impairment of energy-dependent uptake by renal cortex slices.
    Sarangarajan R; Cacini W
    Pharmacol Toxicol; 1997 Oct; 81(4):197-8. PubMed ID: 9353851
    [No Abstract]   [Full Text] [Related]  

  • 16. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
    Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
    Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of platinum levels in plasma, urine, and kidney on blood urea nitrogen levels after cisplatin injection in rats.
    Uozumi J; Litterst CL
    J Pharmacobiodyn; 1988 Apr; 11(4):277-83. PubMed ID: 3411443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cis-diamminedichloroplatinum (II)--induced renal toxicity in the rat.
    Jones MM; Basinger MA; Mitchell WM; Bradley CA
    Cancer Chemother Pharmacol; 1986; 17(1):38-42. PubMed ID: 3698175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional impairment of renal organic cation transport in experimental diabetes.
    Grover B; Auberger C; Sarangarajan R; Cacini W
    Pharmacol Toxicol; 2002 Apr; 90(4):181-6. PubMed ID: 12076311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of disopyramide and verapamil on renal disposition and nephrotoxicity of cisplatin in rats.
    Hanada K; Odaka K; Kudo A; Ogata H
    Pharm Res; 1999 Oct; 16(10):1589-95. PubMed ID: 10554102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.